The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis

This publication has 118 references indexed in Scilit:

• The Genotype-Tissue Expression (GTEx) project
  Nature Genetics, 2013
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
  Science Signaling, 2013
• Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
  Oncology Reports, 2012
• Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells
  Urologic Oncology: Seminars and Original Investigations, 2012
• The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
  Cancer Discovery, 2012
• Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation
  Biochemical and Biophysical Research Communications, 2012
• Mutations and epimutations in the origin of cancer
  Experimental Cell Research, 2012
• Aberrant Splicing of Cyclin-Dependent Kinase–Associated Protein Phosphatase KAP Increases Proliferation and Migration in Glioblastoma
  Cancer Research, 2007
• Protein Tyrosine Phosphatases in the Human Genome
  Cell, 2004
• Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3)
  Cytogenetic and Genome Research, 1995